PRDM9
protein-codingPR/SET domain 9, the group of Lysine methyltransferases|PR/SET domain family|Zinc fingers C2H2-type
Gene summary
The protein encoded by this gene is a zinc finger protein with histone methyltransferase activity that catalyzes histone H3 lysine 4 trimethylation (H3K4me3) during meiotic prophase. This protein contains multiple domains, including a Kruppel-associated box (KRAB) domain, an SSX repression domain (SSXRD), a PRD1-BF1 and RIZ homologous region, a subclass of SET (PR/SET) domain, and a tandem array of C2H2 zinc fingers. The zinc finger array recognizes a short sequence motif, leading to local H3K4me3, and meiotic recombination hotspot activity. The observed allelic variation alters the DNA-binding sequence specificity of the protein, resulting in distinct meiotic recombination hotspots amongst individuals and populations. Multiple alternate alleles of this gene have been described. [provided by RefSeq, Jul 2015]
- MSBP3
MANE transcript
Inheritance
ClinVar variants
Top phenotype
gnomAD constraint
Max pathogenic AF
Genomic locus
External References & Databases
Transcript & Mutation Effects
hg38 • Region Span ~84.5 kbGenCC Phenotypes & Disease Associations
Curated gene-disease validity assertions and inheritance patterns
Inheritance Pattern: AD
Disease ID:MONDO:0005387
Submitter: PanelApp Australia
ClinVar Associated Diseases & Phenotypes
Reported disease conditions connected to PRDM9 variants in ClinVar
ClinVar Variants & Pathogenicity by Type
Statistics based on transcript NM_020227.4. Only rare variants are included.
We include only reliable ClinVar variants with their consequences to MANE Select, MANE Plus Clinical transcripts, or transcripts with TSL equal to 1. Click a count to filter the variants table below.
Slight differences between displayed counts and ClinVar may occur due to a different transcript/consequence chosen by our variant effect predictor, or because we classify Benign/Likely benign as Likely benign and Pathogenic/Likely pathogenic as Likely pathogenic.
| Effect | PathogenicP | Likely pathogenicLP | VUS | Likely benignLB | BenignB | Sum |
|---|---|---|---|---|---|---|
| synonymous | 6 | 2 | 8 | |||
| missense | 2 | 138 | 13 | 153 | ||
| nonsense | 1 | 1 | ||||
| start loss | 0 | |||||
| frameshift | 0 | |||||
| splice donor/acceptor (+/-2bp) | 2 | 2 | ||||
| Total | 3 | 0 | 140 | 19 | 2 | 164 |
Highest pathogenic variant AF is 0.0000260264
Transcript Catalog
Annotated transcript isoforms across RefSeq and Ensembl databases
| Transcript ID | Source | Protein ID | Coding Exons | MANE Status |
|---|---|---|---|---|
| RefSeq | NP_064612.2 | 10 | MANE Select | |
| Ensembl | ENSP00000296682.4 | 10 | MANE Select | |
| RefSeq | NP_001363829.1 | 10 | Standard | |
| Ensembl | ENSP00000425471.2 | 10 | Standard |
Gene Ontology (GO) Annotations & Pathways
Biological processes, molecular functions, cellular components and pathways
Pathways ConsensusPathDB
- Lysine degradation - Homo sapiens (human)
- Reproduction
- PKMTs methylate histone lysines
- Chromatin modifying enzymes
- Meiotic recombination
Biological Process
- meiotic gene conversion
- regulation of transcription by RNA polymerase II
- positive regulation of reciprocal meiotic recombination
- nucleosome positioning
- histone H3-K4 methylation
Molecular Function
- RNA polymerase II regulatory region sequence-specific DNA binding
- DNA-binding transcription factor activity, RNA polymerase II-specific
- DNA-binding transcription factor activity
- recombination hotspot binding
- histone-lysine N-methyltransferase activity
Cellular Component
- nucleus
- nucleoplasm
- chromosome
gnomAD Constraint
Source:
- Gene type
- protein_coding
- Transcript type
- protein_coding
- Transcript
- ENST00000296682
- Coding exons
- 10
- Length
- 21443
- Individuals with no LoFs
- 125516
- Homozygous LoFs
- 0
- Heterozygous LoFs
- 231
- Defined
- 125747
- p
- 0.000919
| Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible | |
|---|---|---|---|---|---|---|
| Missense | -0.746 | 507 | 462 | 1.10 | 0.0000254 | 5781 |
| Missense (PolyPhen) | 103 | 116.4 | 0.88486 | 1397 | ||
| Synonymous | -0.734 | 183 | 171 | 1.07 | 0.00000867 | 1637 |
| Loss of Function | -0.0832 | 40 | 39.4 | 1.01 | 0.00000215 | 485 |
Population LoF Frequency
| Population | CAF | p-value | Status |
|---|---|---|---|
| African | 0.0062 | 0.0059 | notable |
| Latino/Admixed American | 0.0012 | 0.0012 | notable |
| Ashkenazi Jewish | 0.0013 | 0.0013 | notable |
| East Asian | 0.0010 | 0.00071 | notable |
| Finnish | 0.000092 | 0.000092 | rare |
| European (Non-Finnish) | 0.00043 | 0.00042 | rare |
| South Asian | 0.00049 | 0.00049 | rare |
| Other | 0.00083 | 0.00081 | rare |
dbNSFP Gene Annotations
Source:
- Function
- FUNCTION: Histone methyltransferase that specifically trimethylates 'Lys-4' of histone H3 during meiotic prophase and is essential for proper meiotic progression. Does not have the ability to mono- and dimethylate 'Lys-4' of histone H3. H3 'Lys-4' methylation represents a specific tag for epigenetic transcriptional activation. Plays a central role in the transcriptional activation of genes during early meiotic prophase (By similarity). {ECO:0000250}.;
Intolerance Scores
- LoFtool
- 0.973
- RVIS EVS
- 1.32
- RVIS percentile EVS
- 94.07
Essentials
- Essential (CRISPR)
- N
- Essential (CRISPR2)
- S
- Essential (gene trap)
- K
- Indispensability pred.
- N
- Indispensability score
- 0.0231
Gene Damage Prediction
| All | Recessive | Dominant | |
|---|---|---|---|
| Mendelian | Medium | Medium | Medium |
| Primary Immunodeficiency | Medium | Medium | Medium |
| Cancer | Medium | Medium | Medium |